These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 34134089)

  • 1. In response to the letter to the editor by Soha Ghanian et al. re our publication "Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males".
    Isidori AM; Marcelli M; Castagna MG; Baldassarri M; Fava F; Renieri A
    EBioMedicine; 2021 Jun; 68():103426. PubMed ID: 34134089
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor re: Baldassarri et al., 2021 "Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males".
    Ghanian S; Wambier CG
    EBioMedicine; 2021 Jun; 68():103425. PubMed ID: 34134086
    [No Abstract]   [Full Text] [Related]  

  • 3. Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males.
    Baldassarri M; Picchiotti N; Fava F; Fallerini C; Benetti E; Daga S; Valentino F; Doddato G; Furini S; Giliberti A; Tita R; Amitrano S; Bruttini M; Croci S; Meloni I; Pinto AM; Iuso N; Gabbi C; Sciarra F; Venneri MA; Gori M; Sanarico M; Crawley FP; Pagotto U; Fanelli F; Mezzullo M; Dominguez-Garrido E; Planas-Serra L; Schlüter A; Colobran R; Soler-Palacin P; Lapunzina P; Tenorio J; Pujol A; Castagna MG; Marcelli M; Isidori AM; Renieri A; Frullanti E; Mari F;
    EBioMedicine; 2021 Mar; 65():103246. PubMed ID: 33647767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor polyQ alleles and COVID-19 severity in men: A replication study.
    López-Rodríguez R; Ruiz-Hornillos J; Cortón M; Almoguera B; Minguez P; Pérez-Tomás ME; Barreda-Sánchez M; Mancebo E; Ondo L; Martínez-Ramas A; Fernández-Caballero L; Taracido-Fernández JC; Herrero-González A; Mahillo I; ; Paz-Artal E; Guillén-Navarro E; Ayuso C
    Andrology; 2023 Jan; 11(1):24-31. PubMed ID: 36375449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen sensitivity gateway to COVID-19 disease severity.
    Wambier CG; Goren A; Vaño-Galván S; Ramos PM; Ossimetha A; Nau G; Herrera S; McCoy J
    Drug Dev Res; 2020 Nov; 81(7):771-776. PubMed ID: 32412125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Letter to the Editor Regarding Torres-Costa et al "SARS-CoV-2 in Ophtalmology: Current Evidence and Recommendations for Clinical Practice"].
    Martins TGDS
    Acta Med Port; 2021 Jan; 34(1):63. PubMed ID: 33092689
    [No Abstract]   [Full Text] [Related]  

  • 7. Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients.
    McCoy J; Wambier CG; Herrera S; Vaño-Galván S; Gioia F; Comeche B; Ron R; Serrano-Villar S; Iwasiow RM; Tayeb MA; Cadegiani FA; Mesinkovska NA; Shapiro J; Sinclair R; Goren A
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):e15-e17. PubMed ID: 32977355
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: "
    Rani R
    Assay Drug Dev Technol; 2021 Oct; 19(7):408-409. PubMed ID: 34463124
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?' Refers to PII: S2210-7789(21)00538-9.
    Jayaram A; Buhimschi IA; Buhimschi CS
    Pregnancy Hypertens; 2022 Mar; 27():94-95. PubMed ID: 34973599
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter to the editor regarding article: Impact of COVID-19 outbreak on lifestyle behaviour: A review of studies published in India (Rawat et al.).
    Mirzaei F; Tavilani A; Abbasi-Oshaghi E
    Diabetes Metab Syndr; 2021; 15(3):1053-1054. PubMed ID: 33895088
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging pulmonary histopathological findings in COVID-19 patients- a letter to the editor in response to Grosse et al. 2020.
    Parmar D; Ponnampalam J; Seligmann G; Gandhi T
    Cardiovasc Pathol; 2021; 51():107302. PubMed ID: 33152459
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter to the Editor in Response to Khazanchi et al.
    Nayak A; Islam SJ; Mehta A; Quyyumi AA
    J Gen Intern Med; 2021 Apr; 36(4):1113-1114. PubMed ID: 33469749
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter to the Editor in response to article: Hypocalcemia is associated with severe COVID-19: A systematic review and meta-analysis (Martha et al.).
    Siniorakis EE; Arvanitakis SG; Elkouris MJ
    Diabetes Metab Syndr; 2021; 15(3):1059-1060. PubMed ID: 33814294
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter in response to letter to the editor by Singh and Dhibar regarding the article "COVID-19: From bench to bedside" (Singh et al.).
    Singh A; Shaikh A; Singh R; Singh AK
    Diabetes Metab Syndr; 2020; 14(5):865. PubMed ID: 32562863
    [No Abstract]   [Full Text] [Related]  

  • 15. No Role for Reintroducing OPV into the United States with Respect to Controlling COVID-19 [Response to the letter to the Editor by Chumakov et al.].
    Thompson KM; Kalkowska DA; Badizadegan K
    Risk Anal; 2021 Feb; 41(2):389-392. PubMed ID: 33590518
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter to the editor in response to Buja et al. 2020.
    Parmar D; Gandhi T; Ahmad M; Kirresh A; Seligmann G
    Cardiovasc Pathol; 2021; 50():107269. PubMed ID: 32871258
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter to the editor in response to the article: "Vitamin D concentrations and COVID-19 infection in UK biobank" (Hastie et al.).
    Davies G; Mazess RB; Benskin LL
    Diabetes Metab Syndr; 2021; 15(2):643-644. PubMed ID: 33722481
    [No Abstract]   [Full Text] [Related]  

  • 18. Response letter: Letter to the editor regarding Wei W et al.: ''Experience of the Hubei cancer hospital in Wuhan, China".
    Bi J; Wei W; Hu D; Han G
    Radiother Oncol; 2021 Feb; 155():e8-e9. PubMed ID: 32898560
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter to the Editor in response to the article 'Candidate drugs against SARS-CoV-2 and COVID-19'.
    Campesi I; Montella A; Franconi F
    Pharmacol Res; 2021 Jan; 163():105285. PubMed ID: 33160068
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter to editor in response to article "COVID-19: From bench to bedside" (Singh et al.).
    Singh H; Dhibar DP
    Diabetes Metab Syndr; 2020; 14(5):807. PubMed ID: 32535453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.